HC Wainwright & Co. Maintains Buy on Endeavour Silver, Lowers Price Target to $5.5
HC Wainwright & Co. analyst Heiko Ihle maintains Endeavour Silver (NYSE:EXK) with a Buy and lowers the price target from $6 to $5.5.
Endeavour Silver Q4 EPS $0.04 Misses $0.07 Estimate
Endeavour Silver (NYSE:EXK) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.07 by 42.86 percent.
Earnings Scheduled For March 2, 2023
Companies Reporting Before The Bell
• argenx (NASDAQ:ARGX) is expected to report quarterly loss at $3.03 per share on revenue of $176.89 million.
HC Wainwright & Co. Reiterates Buy on Endeavour Silver, Maintains $6 Price Target
HC Wainwright & Co. analyst Heiko Ihle reiterates Endeavour Silver (NYSE:EXK) with a Buy and maintains $6 price target.
Endeavour Silver Q3 Adj EPS $(0.02) Misses $0.02 Estimate, Sales $39.70M Miss $42.31M Estimate
Endeavour Silver (NYSE:EXK) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.02 by 200 percent. This is a 100 percent decrease over losses of $(0.01) per share from the
Earnings Scheduled For November 8, 2022
Companies Reporting Before The Bell
• Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
B. Riley Securities Maintains Buy on Endeavour Silver, Lowers Price Target to $7
B. Riley Securities analyst Lucas Pipes maintains Endeavour Silver (NYSE:EXK) with a Buy and lowers the price target from $8 to $7.
Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday
Gainers
LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.
